dengu
viru
denv
member
famili
flavivirida
four
distinct
serotyp
design
fifti
million
peopl
estim
becom
infect
dengu
viru
annual
approxim
infect
lead
dengu
hemorrhag
fever
dhf
dengu
shock
syndrom
dss
mortal
rate
licens
vaccin
specif
antivir
treatment
avail
prevent
dengu
infect
consid
major
public
health
problem
subtrop
tropic
region
dengu
viru
infect
character
headach
biphas
fever
prostrat
rash
pain
variou
part
bodi
leukopenia
lymphadenopathi
sever
case
infect
progress
dhf
occur
infect
one
serotyp
caus
individu
suffer
moresever
diseas
subsequ
infect
differ
serotyp
dhf
sever
febril
diseas
character
abnorm
hemostasi
increas
vascular
permeabl
instanc
result
hypovolem
shock
syndrom
dss
immun
cell
enhanc
preexist
nonneutr
antibodi
direct
dengu
viral
protein
although
exact
mechan
yet
resolv
howev
host
viral
factor
genet
infect
viral
strain
implic
contribut
diseas
sever
denv
like
flavivirus
three
structur
protein
structur
protein
origin
encod
polyprotein
singl
long
open
read
frame
orf
later
cleav
co
posttransl
cellular
viral
proteas
produc
c
e
protein
amino
terminu
polyprotein
viru
also
express
seven
nonstructur
protein
deriv
carboxyl
termin
sequenc
polyprotein
positivestrand
rna
viral
genom
packag
lipid
bilay
function
protein
summar
tabl
orf
flank
untransl
region
compris
conserv
cisact
rna
secondari
structur
element
requir
mrna
translat
replic
denv
encod
glycosyl
transferas
enzym
requir
host
cell
provid
necessari
complet
synthesi
viral
glycoprotein
includ
glycosyl
process
date
nglycosyl
site
identifi
three
denv
protein
prmm
e
biosynthesi
viral
glycoprotein
requir
transfer
oligosaccharid
precursor
bud
protein
termin
glucos
residu
core
unit
trim
involv
sequenti
trim
three
glucos
residu
attach
oligosaccharid
catalyz
endoplasm
reticulum
er
ii
enzym
cleav
outer
glucos
residu
wherea
ii
cleav
two
inner
glucos
residu
leav
protein
monoglycosyl
action
allow
glycoprotein
bind
er
chaperon
calnexin
andor
calreticulin
properli
fold
downstream
reglycosyl
process
initi
incomplet
fold
protein
udpglucosyltransferas
act
sensor
correct
protein
fold
correctli
fold
protein
releas
deglycosyl
cycl
transport
golgi
complex
process
e
glycoprotein
monom
three
structur
function
domain
domain
hing
region
contain
amino
terminu
domain
ii
respons
stabil
dimer
contain
fusion
peptid
domain
iii
immunoglobulin
ig
like
domain
contain
put
receptorbind
motif
glycoprotein
one
potenti
nlink
glycosyl
motif
form
x
amino
acid
except
prolin
studi
shown
number
locat
motif
vari
significantli
among
denv
subtyp
glycosyl
motif
commonli
observ
domain
residu
asparagin
addit
glycan
residu
absolut
requir
infect
although
glycosyl
essenti
residu
sever
studi
shown
mutat
occur
nlink
glycosyl
site
e
glycoprotein
affect
virusmedi
membran
fusion
neurovirul
glycosyl
mutant
describ
glycoprotein
e
differ
amino
acid
note
four
wildtyp
denv
serotyp
amino
acid
glutam
acid
denv
denv
aspart
acid
denv
denv
anoth
nlink
glycosyl
motif
denv
occur
mediat
viral
infect
dendrit
cell
bear
dcsign
receptor
essenti
viral
assembl
exit
remov
glycan
shown
sever
affect
viral
fit
reduc
cell
infect
glycosyl
denv
prmm
glycoprotein
extens
studi
prm
protein
fuse
ectodomain
e
glycoprotein
glycosyl
modif
asparagin
potenti
nlink
glycosyl
site
also
identifi
residu
glycosyl
prm
may
allow
act
chaperon
e
protein
fold
er
permit
associ
membran
allow
act
assembl
e
protein
glycosyl
begin
monom
alter
within
er
lumen
addit
highmannosetyp
glycan
nlink
glycosyl
site
subsequ
rapid
dimer
pryor
wright
demonstr
secret
treat
endoglycosidas
h
complex
glycan
attach
highmannos
glycan
nlink
glycosyl
site
alter
carbohydr
moieti
dimer
occur
golgi
apparatu
protein
transport
cell
surfac
releas
infect
cell
interestingli
presenc
polymannosetyp
sugar
dimer
may
protect
one
nglycan
matur
golgi
without
stabil
dimer
secret
glycoprotein
would
reduc
glycosyl
essenti
viral
process
rang
replic
virul
unclear
point
glycosyl
affect
process
carbohydr
chain
also
known
glycan
one
four
basic
compon
cell
remark
structur
divers
usual
exist
coval
linkag
saccharid
conjug
protein
glycoprotein
lipid
glycolipid
cell
surfac
glycan
mammal
well
conserv
although
speciesspecif
variat
occur
variat
glycan
involv
interact
may
determin
suscept
specif
organ
infecti
pathogen
differ
type
glycan
produc
glycosyl
depend
type
residu
attach
cellular
protein
lipid
glycosyl
protein
involv
nglycan
oglycan
glycosaminoglycan
frequent
known
proteoglycan
nglycan
form
bind
specif
subset
n
residu
protein
locat
motif
wherea
oglycan
attach
subset
serin
threonin
residu
linear
glycosaminoglycan
also
serin
threoninelink
usual
highli
sulfat
lipid
glycosyl
also
common
modif
secretori
pathway
produc
glycolipid
also
known
glycosphingolipid
includ
sialicacidbear
gangliosid
propag
viru
diseas
progress
depend
direct
interact
viru
host
cell
receptor
differ
virus
may
prefer
differ
glycan
moieti
attach
charg
glycan
moieti
sialic
acid
readili
recogn
orthoreovirus
rotavirus
influenza
virus
heparan
sulfat
recogn
herp
virus
parvovirus
neutral
glycan
histoblood
group
antigen
bound
rotavirus
norovirus
signific
divers
recognit
specif
glycan
within
particular
viral
speci
aris
genet
differ
dictat
cell
tropism
host
specif
adapt
interspeci
transmiss
pathogenesi
viru
four
major
type
receptor
mammal
believ
target
denv
carbohydr
molecul
carbohydratebind
protein
also
known
lectin
factor
relat
protein
fold
chaperon
heat
shock
protein
protein
highaffin
laminin
receptor
protein
howev
review
focus
molecul
contain
carbohydr
moieti
tabl
carbohydr
carbohydratebind
protein
receptor
discuss
group
receptor
includ
sulfat
glycosaminoglycan
gag
glycosphingolipid
act
coreceptor
molecul
enhanc
effici
viral
entri
heparan
sulfat
among
sulfat
gag
involv
initi
attach
denv
cell
surfac
e
glycoprotein
bind
molecul
recent
okamoto
et
al
show
specif
heparan
sulfat
proteoglycan
call
membran
heparan
sulfat
proteoglycan
util
denv
receptor
heparan
sulfat
linear
repeat
copolym
variabl
sulfat
uron
acid
glucosamin
carbohydr
residu
highli
neg
charg
found
cell
surfac
also
extracellular
matrix
anoth
type
carbohydr
molecul
report
recent
neolactotetraosylceramid
glycosphingolipid
sulfat
carbohydr
molecul
may
coreceptor
denv
assist
attach
viru
host
cell
denv
interact
glycosphingolipid
nonreduc
terminu
express
surfac
suscept
cell
human
erythroleukemia
babi
hamster
kidney
cell
protein
commonli
group
clectin
express
dendrit
cell
macrophag
locat
human
skin
known
play
import
role
initi
contact
denv
introduc
mosquito
bite
bestcharacter
lectin
involv
interact
viru
dendrit
cell
dendrit
cellspecif
intercellular
adhes
nonintegrin
dcsign
dcsign
classifi
member
calciumdepend
ctype
lectin
famili
affin
highmannos
glycan
found
differ
pathogen
includ
ebola
viru
hepat
c
viru
human
immunodefici
viru
hiv
sever
parasit
yeast
bacteria
interact
dcsign
denv
occur
highmannos
nlink
glycan
found
e
glycoprotein
interact
confirm
studi
navarrosanchez
et
al
tassaneetrithep
et
al
group
success
inhibit
denv
infect
introduc
solubl
dcsign
antibodi
direct
dcsign
howev
intern
dcsign
essenti
denv
infect
lectin
may
function
specif
receptor
may
allow
attach
concentr
viru
cell
surfac
phenomenon
explain
studi
attach
e
glycoprotein
carbohydr
moieti
dcsign
e
glycoprotein
bind
carbohydraterecognit
domain
dcsign
conform
chang
e
glycoprotein
matur
viru
even
though
chang
observ
fulllength
dcsign
molecul
bind
glycoprotein
howev
bind
leav
singl
e
glycoprotein
asymmetr
unit
vacant
put
receptorbind
domain
iii
present
e
glycoprotein
free
bind
receptor
icosahedr
fivefold
threefold
axe
dcsign
oligomer
state
surfac
cell
occur
tetram
interact
viru
bind
dcsign
could
promot
viral
cluster
cell
surfac
facilit
bind
receptor
propos
interact
carbohydr
moieti
dcsign
mimic
normal
cellular
process
therefor
protect
receptorbind
domain
e
protein
host
immun
surveil
neutral
macrophag
bear
ctype
lectin
receptor
mannos
receptor
ctype
lectin
domain
famili
member
mannos
receptor
shown
bind
denv
japanes
enceph
viru
tickborn
meningoenceph
viru
mechan
similar
mechan
dcsign
bind
howev
ligand
specif
mannos
receptor
differ
dcsign
ligand
termin
mannos
fucos
nacetyl
glucosamin
rather
highmannos
oligosaccharid
fucosyl
glycan
hypothes
mannos
receptor
attach
molecul
denv
intern
cell
infect
found
mainli
endocyt
pathway
unlik
dcsign
mainli
restrict
plasma
membran
also
call
myeloid
lectin
classifi
type
ii
transmembran
receptor
found
surfac
macrophag
monocyt
receptor
contain
ctype
lectinlik
domain
ctermin
extracellular
region
four
amino
acid
predict
ntermin
cytoplasm
region
receptor
recogn
potenti
denv
receptor
bind
denv
contribut
significantli
mortal
associ
denv
infect
trigger
excess
macrophag
activ
chen
et
al
demonstr
surviv
rate
mice
increas
block
human
mous
report
bind
denv
interact
inhibit
mannos
fucos
vitro
understand
mechan
contribut
invas
host
cell
discuss
may
clarifi
specif
agent
interrupt
modifi
viral
replic
express
use
limit
damag
caus
infect
synthesi
nglycan
may
interrupt
sever
stage
inhibit
specif
enzym
rough
er
tunicamycin
inhibit
transfer
trimannos
core
asparagin
residu
remov
termin
glucos
residu
may
block
nojirimycin
castanospermin
phosphatasemedi
convers
dolichylpyrophosph
releas
glycosid
cleavag
inhibit
bacitracin
brefeldin
inhibit
transport
result
highmannos
nglycan
golgi
apparatu
process
mannosidas
enzym
may
affect
deoxymannojirimycin
swainsonin
deoxynojirimycin
inhibitor
er
disrupt
trim
termin
glucos
thu
affect
subsequ
fold
pathway
denv
glycoprotein
prm
e
plant
lectin
also
known
carbohydratebind
agent
cba
recent
emerg
potent
agent
treatment
denv
infect
target
initi
attach
viru
cell
sever
cba
uniqu
properti
specif
tabl
identifi
use
block
virus
lectin
bind
specif
mannos
moieti
rang
termin
mannosyl
residu
highmannos
glycan
target
wide
rang
virus
antivir
activ
cba
denv
recent
explor
particularli
lectin
hippeastrum
hybrid
hha
galanthu
nivali
gna
urtica
dioica
uda
initi
found
inhibit
interact
hiv
dcsignexpress
cell
cba
also
shown
dosedepend
inhibit
interact
four
serotyp
denv
dcsign
rajidcsign
cell
monocytederiv
dendrit
cell
bind
assay
shown
cba
interact
cellular
membran
protein
instead
interact
directli
viral
glycosyl
envelop
protein
concanavalin
cona
wheatgerm
agglutinin
reduc
develop
plaqu
induc
denv
bhk
cell
competit
assay
use
mannos
show
inhibitori
effect
cona
result
bind
residu
viral
protein
howev
lectin
complet
inhibit
denv
introduc
individu
infect
cell
therefor
studi
effect
combin
cba
requir
import
denv
glycosyl
interact
carbohydr
receptor
warrant
investig
develop
effici
treatment
denvrel
diseas
avail
drug
disrupt
protein
glycosyl
result
incomplet
matur
denv
case
sever
dengu
infect
denv
replic
enhanc
antibodydepend
enhanc
mechan
drug
anticip
effect
limit
viral
replic
thu
reduc
viral
load
may
lessen
sever
diseas
aforement
drug
design
inhibit
human
glycosyl
enzym
whether
drug
elicit
similar
effect
glycosyl
enzym
denv
vector
must
explor
date
studi
specif
explor
denv
protein
glycosyl
process
mosquito
howev
mason
demonstr
abil
mosquito
cell
line
releas
matur
glycosyl
e
glycoprotein
japanes
enceph
viru
anoth
member
famili
flavivirida
therefor
predict
denv
also
undergo
glycosyl
mosquito
glycosyl
inhibitor
anticip
effect
degre
although
drug
disturb
glycosyl
process
format
viral
glycoprotein
may
seem
use
context
drug
may
also
disturb
glycosyl
cellular
glycoprotein
howev
cba
lectin
act
directli
viral
interact
cell
surfac
need
fuse
cell
exert
antivir
activ
therefor
anticip
cba
interfer
synthesi
glycan
cellsurfac
glycoprotein
potenti
util
lectin
antivir
agent
seem
promis
antivir
potenc
lectin
viru
may
differ
threedimension
conform
differ
avail
glycan
conform
proper
carbohydr
moieti
differ
across
viral
protein
sever
challeng
must
still
address
high
cost
purif
mass
product
lectin
storag
stabil
bioavail
cellular
toxic
howev
issu
may
resolv
design
synthet
cba
structur
similar
natur
molecul
stabl
nontox
sever
synthet
molecul
alreadi
avail
provid
basi
explor
potenti
therapeut
cba
drug
deliveri
use
especi
design
capsul
nanocarri
may
also
use
strategi
combat
bioavail
problem
base
factor
cba
consid
valuabl
class
antivir
agent
warrant
investig
eventu
applic
clinic
set
